alpha-Neu5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer

Term ID

CHEBI:62267

Synonyms

(2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(glycoloylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
(Gal)1 (Glc)1 (Neu5Gc)1 (Cer)1
alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
alpha-Neu5Gc-(2->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer
GM3 (NeuGc)
GM3(Gc)
GM3(NeuGc)
GM3-NeuGc
HD3
Neu5Gc(alpha2-3)Gal(beta1-4)Glc(beta1-1)Cer
Neu5Gcalpha2-3Galbeta1-4Glcbeta1-1'Cer

Definition

A sialodiosylceramide in which the sialic acid residue is linked to the ceramide moiety by a beta-galactosyl-(1->4)-beta-glucosyl chain.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neu5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer

Phenotype where environments contain alpha-Neu5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer

Phenotype modified by environments containing alpha-Neu5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer

Human Disease Model